HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

William B Stallcup Selected Research

chondroitin sulfate proteoglycan 4

1/2016NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
1/2014NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.
1/2012Ablation of NG2 proteoglycan leads to deficits in brown fat function and to adult onset obesity.
8/2010Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.
7/2008A role for the NG2 proteoglycan in glioma progression.
4/2005Differential responses of spinal axons to transection: influence of the NG2 proteoglycan.
1/2004Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


William B Stallcup Research Topics

Disease

10Neoplasms (Cancer)
01/2014 - 11/2002
5Anoxia (Hypoxia)
01/2014 - 06/2005
4Melanoma (Melanoma, Malignant)
03/2012 - 11/2005
3Breast Neoplasms (Breast Cancer)
01/2015 - 06/2005
3Spinal Cord Injuries (Spinal Cord Injury)
12/2014 - 04/2002
2Atherosclerosis
01/2016 - 05/2009
2Obesity
01/2016 - 01/2012
2Corneal Neovascularization
04/2013 - 01/2004
2Inflammation
07/2010 - 05/2009
2Glioma (Gliomas)
07/2008 - 05/2006
1Hyperlipidemias (Hyperlipidemia)
01/2016
1Diabetic Retinopathy (Retinopathy, Diabetic)
02/2014
1Open-Angle Glaucoma (Glaucoma, Open Angle)
02/2014
1Sarcoma (Soft Tissue Sarcoma)
06/2013
1Neoplasm Metastasis (Metastasis)
06/2013
1Vascular Tissue Neoplasms
03/2012
1Brain Neoplasms (Brain Tumor)
03/2012
1Demyelinating Diseases (Demyelinating Disease)
01/2011
1Bites and Stings (Sting)
08/2010
1Multiple Sclerosis
10/2009
1Atherosclerotic Plaque (Atheroma)
05/2009
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2007
1Prostatic Neoplasms (Prostate Cancer)
05/2007
1Leukemia
05/2007
1Cicatrix (Scar)
04/2005
1Pathologic Neovascularization
01/2004
1Wounds and Injuries (Trauma)
04/2002

Drug/Important Bio-Agent (IBA)

7chondroitin sulfate proteoglycan 4IBA
01/2016 - 01/2004
5Chondroitin Sulfate ProteoglycansIBA
12/2014 - 04/2002
5Proteoglycans (Proteoglycan)IBA
06/2013 - 04/2005
4glucuronyl glucosamine glycan sulfate (Vessel)IBA
01/2014 - 08/2010
3CollagenIBA
06/2013 - 11/2005
2Apolipoproteins E (ApoE)IBA
01/2016 - 05/2009
2Retinaldehyde (Retinal)IBA
02/2014 - 01/2004
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2012 - 06/2005
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2012 - 06/2005
1Lipoproteins (Lipoprotein)IBA
01/2016
1RNA (Ribonucleic Acid)IBA
01/2015
1Collagen Type VIIBA
06/2013
1tumor-associated antigen GA733IBA
08/2010
1Bispecific AntibodiesIBA
08/2010
1Proteins (Proteins, Gene)IBA
08/2010
1AntibodiesIBA
08/2010
1AntigensIBA
08/2010
1Complement System Proteins (Complement)IBA
08/2010
1Monoclonal AntibodiesIBA
08/2010
1HMW-MAAIBA
08/2010
1Surface Antigens (Surface Antigen)IBA
08/2010
1CytokinesIBA
07/2010
1copolymer 1 (glatiramer acetate)FDA Link
10/2009
1oxidized low density lipoproteinIBA
05/2009
1Aryldialkylphosphatase (Paraoxonase)IBA
05/2009
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2009
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2009
1Platelet-Derived Growth Factor alpha ReceptorIBA
07/2008
1Hydroxamic Acids (Hydroxamic Acid)IBA
05/2007
1thiazolidine-2,4-dioneIBA
05/2007
11H-tetrazole (tetrazole)IBA
05/2007
14- (3- (1- adamantyl)- 4- hydroxyphenyl)- 3- chlorocinnamic acidIBA
05/2007
1HydrogenIBA
05/2007
1Protein Tyrosine PhosphatasesIBA
05/2007
1Carbon MonoxideIBA
05/2006
1Galectin 3 (LGALS3)IBA
05/2006
1erbB-2 Receptor (Receptor, erbB 2)IBA
06/2005
1Sirolimus (Rapamycin)FDA Link
06/2005
1Calcitonin Gene-Related PeptideIBA
04/2005
1fluorescein isothiocyanate dextranIBA
01/2003
1PlasticsIBA
11/2002

Therapy/Procedure

1Homologous Transplantation (Allograft)
01/2012
1Transplantation (Transplant Recipients)
01/2003